Research Article
The Predictability of Cystatin C for Peripheral Arterial Disease in Chinese Population with Type 2 Diabetes Mellitus
Table 1
Baseline characteristics of studied population.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: PAD: peripheral artery disease; BMI: body mass index; FPG: fasting blood glucose levels; HbA1C: glycosylated hemoglobin; TG: triglyceride; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; HCY: homocysteine; ALT: alanine aminotransferase; AST: aspartate aminotransferase; RBC: red blood cell; WBC: white blood cell; PLT: platelets; Fib: fibrinogen; CRP: C reactive protein; URIC: uric acid; BUN: urea nitrogen; CREA: creatinine; eGFR: estimated glomerular filtration rate; BMG: beta 2 microglobulin; CysC: cystatin C; RBP: retinol binding protein; uMALB: urine microalbumin; uCREA: urine creatinine; CHD: coronary heart disease; CVD: cerebrovascular disease. |